These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9421693)

  • 1. Treatment of patients with essential hypertension and microalbuminuria.
    Redon J
    Drugs; 1997 Dec; 54(6):857-66. PubMed ID: 9421693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and microalbuminuria: the new detrimental duo.
    Verdecchia P; Reboldi GP
    Blood Press; 2004; 13(4):198-211. PubMed ID: 15581333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors associated with changes in microalbuminuria during antihypertensive treatment].
    Rovira E; Julve R; Pascual JM; Miralles A; Redon J
    Med Clin (Barc); 2000 May; 114(19):721-5. PubMed ID: 10919124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria in essential hypertension.
    Mimran A; Ribstein J; Du Cailar G
    Curr Opin Nephrol Hypertens; 1999 May; 8(3):359-63. PubMed ID: 10456269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection by antihypertensive drugs: insights from microalbuminuria studies.
    Redon J
    J Hypertens; 1998 Dec; 16(12 Pt 2):2091-100. PubMed ID: 9886902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension.
    Redon J; Miralles A; Pascual JM; Baldó E; Robles RG; Carmena R
    J Hypertens; 1997 Jan; 15(1):79-86. PubMed ID: 9050974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
    Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
    J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria in essential hypertensives in treatment for hypertension.
    Cruz HM; Cruzera AB; Cruz J
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(5):258-62. PubMed ID: 9595780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.
    Bianchi S; Bigazzi R; Baldari G; Campese VM
    Am J Med; 1992 Nov; 93(5):525-8. PubMed ID: 1442855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.
    Bianchi S; Bigazzi R; Baldari G; Campese VM
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):291-6. PubMed ID: 2059393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.
    Pascual JM; Rodilla E; Gonzalez C; Pérez-Hoyos S; Redon J
    Hypertension; 2005 Jun; 45(6):1125-30. PubMed ID: 15897369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension.
    Ravera M; Ratto E; Vettoretti S; Viazzi F; Leoncini G; Parodi D; Tomolillo C; Del Sette M; Maviglio N; Deferrari G; Pontremoli R
    J Nephrol; 2002; 15(5):519-24. PubMed ID: 12455718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension.
    Pascual JM; Rodilla E; Costa JA; Garcia-Escrich M; Gonzalez C; Redon J
    Hypertension; 2014 Dec; 64(6):1228-34. PubMed ID: 25245391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.